Fatty Liver/Adipose Tissue Dual-Targeting Nanoparticles with Heme Oxygenase-1 Inducer for Amelioration of Obesity, Obesity-Induced Type 2 Diabetes, and Steatohepatitis
- Adv. Sci., First published: 09 October 2022 | https://doi.org/10.1002/advs.202203286